Combined oral contraceptives and liver disease

Contraception

Volumn 55, Issue 3, 1997, Pages 145-151

  Hannaford, Philip C ^a   Kay, Clifford R ^a   Vessey, Martin P ^b   Painter, Rosemary ^b   Mant, Jonathan ^b  

^a ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

cohort study; hepatocellular carcinoma; liver disease; oral contraceptives

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; MESTRANOL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; HEPATITIS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER DISEASE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION;

BIOLOGY; COHORT ANALYSIS; CONTRACEPTION; CONTRACEPTIVE METHODS; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; EUROPE; FAMILY PLANNING; HEPATIC EFFECTS; INCIDENCE; LONGITUDINAL STUDIES; MEASUREMENT; NORTHERN EUROPE; ORAL CONTRACEPTIVES; ORAL CONTRACEPTIVES, COMBINED; PHYSIOLOGY; POPULATION; POPULATION DYNAMICS; RESEARCH METHODOLOGY; RESEARCH REPORT; RISK FACTORS; STUDIES; TIME FACTORS; UNITED KINGDOM;

ADULT; COHORT STUDIES; CONFIDENCE INTERVALS; CONTRACEPTIVES, ORAL, COMBINED; ESTROGENS; FEMALE; GREAT BRITAIN; HEPATITIS; HUMANS; INCIDENCE; LIVER DISEASES; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 0030935331     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(97)00023-1     Document Type: Article

References (35)

1. Petersdorf RG, Adams RD, Braunwald E, Isselbacher KJ, Martin JB, Wilson JD, eds. Harrison's principles of internal medicine. Japan: McGraw-Hill International Book Company, 1983:1798-801.
2. Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 1976;294:470-2.
3. Rooks JB, Ory HW, Ishak KG, et al. Epidemiology of hepatocellular adenoma. JAMA 1979;242:644-8.
4. Brady MS, Coit DG. Focal nodular hyperplasia of the liver. Surg Gynecol Obstet 1990;171:377-81.
5. Henderson BE, Preston-Martin S, Edmondson HA, Peters RL, Pike MC. Hepatocellular carcinoma and oral contraceptives. Br J Cancer 1983;48:437-40.
6. Forman D, Vincent TJ, Doll R. Cancer of the liver and the use of oral contraceptives. Br Med J 1986;292,:1357-61.
7. Neuberger J, Forman D, Doll R, William R. Oral con-traceptives and hepatocellular carcinoma. Br Med J 1986;292:1355-7.
8. La Vecchia C, Negri E, Parzzini F. Oral contraceptives and primary liver cancer. Br J Cancer 1989;59:460-1.
9. Palmer JR, Rosenberg L, Kaufman DW, Warshauer ME, Stolley P, Shapiro S. Oral contraceptive use and liver cancer. Am J Epidem 1989;130:878-82.
10. Vallmayans M, Calvet X, Bruix J, et al. Risk factors for hepatocellular carcinoma in Catalonia, Spain. Int J Cancer 1990;46:378-81.
11. Tavani A, Negri E, Parazzini F, Franceschi S, La Vecchia C. Female hormone utilisation and risk of hepatocellular carcinoma. Br J Cancer 1993;67:635-7.
12. Yu MC, Tong MJ, Govindarahan S, Henderson BE. Nonviral risk factors for hepatocellular carcinoma in a low risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.
13. Hsing AW, Hoover RN, McLaughlin JK, et al. Oral contraceptives and primary liver cancer among young women. Cancer Causes and Control 1992;3:43-8.
14. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Combined oral contraceptives and liver cancer. Int J Cancer 1989;43:254-9.
15. Cote RJ, Urmacher C. Rhabdomyosarcoma of the liver associated with long-term oral contraceptive use: possible role of estrogens in the genesis of embryologically distinct liver tumours. Am J Surg Path 1990;14:784-90.
16. Shi ECP, Fischer A, Crouch R, Ham JM. Possible association of angiosarcoma with oral contraceptive agents. Med J Aust 1981;1:473-4.
17. Monroe PS, Riddell RH, Siegler M, Baker Al. Hepatic angiosarcoma. Possible relationship to long-term oral contraceptive ingestion. JAMA 1981;246:64-5.
18. Mant JWF, Vessey MP. Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives. Br J Cancer 1995;72:800-3.
19. Vessey MP, Doll R, Peto R, Johnson B, Wiggins P. A long-term follow-up study of women using different methods of contraception - an interim report. J Biosoc Sci 1976;8:373-427.
20. Royal College of General Practitioners' Oral Contraception Study. Oral contraceptives and gallbladder disease. Lancet 1982;ii:957-9.
21. Boston Collaborative Drug Surveillance Program. Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Lancet 1973;i:1399-404.
22. Vessey M, Painter R. Oral contraceptive use and benign gallbladder disease revisited. Contraception 1994;50:167-73.
23. Lewis JH, Tice HL, Zimmerman HJ. Budd-Chiari syndrome associated with oral contraceptive steroids: review of treatment of 47 cases. Digest Dis Sci 1983;28:673-83.
24. Capron JP, Lemay JL, Muir JF, Dupas JL, Lebrec D, Gineston JL. Portal vein thrombosis and fatal pulmonary thromboembolism associated with oral contraceptive treatment. J Clin Gastroenterol 1981;3:295-8.
25. Jacobs MB. Hepatic infarction related to oral contraceptive use. Arch Intern Med 1984;144:642-3.
26. van Erpecum KJ, Janssens AR, Kreuning J, Rutter DJ, Kroon HMJA, Grond AJK. Generalized peliosis hepatitis and cirrhosis after long-term use of oral contraceptives. Am J Gastroenterol 1988;83:572-5.
27. Spellberg MA, Mirro J, Chowdhury L. Hepatic sinsusoidal dilatation related to oral contraceptives. Am J Gastroenterol 1979;72:248-52.
28. Camilleri M, Schafler K, Chadwick VS, Hodgson HJ, Weinbren K. Periportal sinusoidal dilatation, inflammatory bowel disease, and the contraceptive pill. Gastroenterology 1981;80:810-5.
29. Weden M, Glaumann H, Einarsson K. Protracted cholestasis probably induced by oral contraceptive. J Int Med 1992;231:561-5.
30. Royal College of General Practitioners. Oral contraceptives and health. London: Pitman Medical, 1974.
31. Breslow NE, Day NE. Statistical methods in cancer research, Vol. II - the design and analysis of cohort studies. Lyon: IARC, 1987.
32. Colditz GA. Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study. Ann Intern Med 1994;120:821-6.
33. Weindling H, Henry JB. Laboratory test results altered by "the pill." JAMA 1974;229:1762-8.
34. Kay CR. The Royal College of General Practitioners' Oral Contraception Study: some recent observations. Clin Obstet Gynaecol 1984;11:759-86.
35. Beral V, Hermon C, Kay C, Hannaford PC, Darby S, Reeves G. Mortality in relation to method of follow-up in the Royal College of General Practitioners' Oral Contraceptive Study. In: Hannaford PC. Webb AMC, eds. Evidence-guided prescribing of the pill. Carterton, UK: Parthenon Publishing Group Ltd, 1996:327-9.